BIG
CRL icon

Brooklyn Investment Group’s Charles River Laboratories CRL Stock Holding History

Brooklyn Investment Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$364K Buy
2,113
+335
+19% +$62.1K 0.01% 1264
2025
Q4 		$361K Buy
+1,778
New +$323K 0.02% 903
2025
Q3 		– Sell
-566
Closed -$85.9K – 1122
2025
Q2 		$85.9K Buy
566
+388
+218% +$51.7K 0.01% 1020
2025
Q1 		$26.8K Buy
178
+86
+93% +$14.4K 0.01% 1029
2024
Q4 		$17K Buy
92
+2
+2% +$385 0.01% 804
2024
Q3 		$17.7K Buy
+90
New +$18.7K 0.01% 677

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brooklyn Investment Group's CRL Position: Q1 2026 in Review

Brooklyn Investment Group increased its Charles River Laboratories (CRL) stake by 19% in Q1 2026, buying an estimated $62.1K and bringing the position to 2,113 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #1264.

Brooklyn Investment Group first reported a position in CRL in Q3 2024 and has held it in 6 quarters since. 559 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Brooklyn Investment Group held 2,113 shares of Charles River Laboratories worth $364K as of Q1 2026.
  • Brooklyn Investment Group bought 335 Charles River Laboratories shares in Q1 2026, an estimated $62.1K.
  • Charles River Laboratories made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1264 holding.
  • Brooklyn Investment Group first reported a position in Charles River Laboratories in Q3 2024 and has held it in 6 quarters since.
  • 559 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.